Sign In
Buy RNXT
$0.96
+0.0171 (+1.82%)
At Close: Jul 31, 2026
RenovoRx Expands Scientific Advisory Board with Appointment of Michel Ducreux, M.D., Ph.D.
08:35am, Thursday, 16'th Nov 2023
LOS ALTOS, Calif.--(BUSINESS WIRE)--RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing targeted combination therapies, today ann
RenovoRx Reports Third Quarter 2023 Financial Results and Operational Highlights
08:30am, Tuesday, 14'th Nov 2023
LOS ALTOS, Calif.--(BUSINESS WIRE)--RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing targeted combination therapies, today ann
RenovoRx to Present at the ROTH MKM Healthcare Opportunities Conference on October 12, 2023
08:30am, Monday, 02'nd Oct 2023
LOS ALTOS, Calif.--(BUSINESS WIRE)--RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing targeted combination therapies, today ann
RenovoRx Reports Second Quarter 2023 Financial Results and Operational Highlights
08:30am, Thursday, 17'th Aug 2023
LOS ALTOS, Calif.--(BUSINESS WIRE)--RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing targeted combination therapies, today ann
RenovoRx to Present at the 43rd Annual Canaccord Genuity Growth Conference
08:30am, Monday, 31'st Jul 2023
LOS ALTOS, Calif.--(BUSINESS WIRE)--RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing targeted combination therapies, today ann
RenovoRx to Participate in the Aegis Capital Virtual Conference on May 3, 2023
08:30am, Friday, 28'th Apr 2023
LOS ALTOS, Calif.--(BUSINESS WIRE)--RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a biopharmaceutical company focused on the localized treatment of solid tumors, announced that
RenovoRx to Present at the 35th Annual Roth Conference on March 13, 2023
08:30am, Wednesday, 01'st Mar 2023
LOS ALTOS, Calif.--(BUSINESS WIRE)--RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a biopharmaceutical company focused on the localized treatment of solid tumors, today announces
RenovoRx to Present at the Sequire Biotechnology Virtual Conference on February 2, 2023
08:30am, Wednesday, 25'th Jan 2023
LOS ALTOS, Calif.--( BUSINESS WIRE )--RenovoRx, Inc. (Nasdaq: RNXT), a biopharmaceutical company focused on the localized treatment of solid tumors, today announced that Shaun Bagai, Chief Executive O
LOS ALTOS, Calif.--(BUSINESS WIRE)--RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today announces that it w
RenovoRx to Participate in March 2022 Investor Conferences
08:30am, Friday, 11'th Mar 2022
LOS ALTOS, Calif.--(BUSINESS WIRE)--RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today announced its leade
5 Short Squeeze Candidates To Watch: Pioneer Power, NuZee Remain At The Top, Grab Rejoins The Leaderboard
10:00am, Monday, 06'th Dec 2021
Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next huge move. GameStop Corp (NYSE:GME) and AMC Entertainment Holdings (NYSE:AMC) are two high-profile
Short Squeeze Stocks: PPSI, NUZE and 3 Others Experts Think Are Ready to Pop
02:14pm, Monday, 29'th Nov 2021
PPSI, NUZE, and three other stocks are ranked highly in Fintel's Short Squeeze Screener. All three names have a score higher than 96.
5 Short Squeeze Candidates To Watch: Pioneer Power Tops List Along With Newegg, Nuzee And More
09:26am, Monday, 29'th Nov 2021
Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next huge move. GameStop Corp (NYSE: GME) and AMC Entertainment Holdings (NYSE: AMC) are two high-profil
RenovoRx (RNXT) Stock: Why The Price Surged Over 130% Today
03:41pm, Wednesday, 10'th Nov 2021
The stock price of RenovoRx Inc (NASDAQ: RNXT) increased by over 130% during intraday trading today. This is why it happened.
Dear FSR Stock Fans, Mark Your Calendars for an EV Catalyst on Nov. 17
10:44am, Wednesday, 10'th Nov 2021
Fisker (FSR) investors are going to want to keep an eye on FSR stock when Nov. 17 rolls around next Wednesday for a big reveal. The post Dear FSR Stock Fans, Mark Your Calendars for an EV Catalyst on
